APA (7th ed.) Citation

Mo, D., Fang, H., Niu, K., Liu, J., Wu, M., Li, S., . . . Zhao, Y. (2016). Human helicase RECQL4 drives cisplatin resistance in gastric cancer by activating an AKT-YB1-MDR1 signaling pathway. American Association for Cancer Research.

Chicago Style (17th ed.) Citation

Mo, Dongliang, et al. Human Helicase RECQL4 Drives Cisplatin Resistance in Gastric Cancer by Activating an AKT-YB1-MDR1 Signaling Pathway. American Association for Cancer Research, 2016.

MLA (9th ed.) Citation

Mo, Dongliang, et al. Human Helicase RECQL4 Drives Cisplatin Resistance in Gastric Cancer by Activating an AKT-YB1-MDR1 Signaling Pathway. American Association for Cancer Research, 2016.

Warning: These citations may not always be 100% accurate.